Cargando…
Detection of residual and chemoresistant leukemic cells in an immune-competent mouse model of acute myeloid leukemia: Potential for unravelling their interactions with immunity
Acute myeloid leukemia (AML) is characterized by blocked differentiation and extensive proliferation of hematopoietic progenitors/precursors. Relapse is often observed after chemotherapy due to the presence of residual leukemic cells, which is also called minimal residual disease (MRD). Subclonal he...
Autores principales: | Mopin, Alexia, Leprêtre, Frédéric, Sebda, Shéhérazade, Villenet, Céline, Ben Khoud, Meriem, Figeac, Martin, Quesnel, Bruno, Brinster, Carine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053800/ https://www.ncbi.nlm.nih.gov/pubmed/35486629 http://dx.doi.org/10.1371/journal.pone.0267508 |
Ejemplares similares
-
Acute Myeloid Leukemia: Is It T Time?
por: Khoud, Meriem Ben, et al.
Publicado: (2021) -
A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
por: Mopin, Alexia, et al.
Publicado: (2016) -
Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2015) -
IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association
por: Debarri, Houria, et al.
Publicado: (2015) -
Simple gene signature to assess murine fibroblast polarization
por: Ledoult, Emmanuel, et al.
Publicado: (2022)